Vertex Pharmaceuticals's total assets for Q4 2024 were $22.53B, an increase of 1.32% from the previous quarter. VRTX total liabilities were $6.12B for the fiscal quarter, a -7.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.